LONDON–Synthace Ltd., the company behind the leading cloud software platform for automating and improving the success rate of biological research and development, today announced the closing of a $25.6m Series B financing round led by Horizons Ventures with additional investment from Luminous Ventures, SOSV and select other individual and large family office investors. Synthace will use […]

US-based Foresite Capital and F-Prime Capital join other leading investors backing UK company at the interface of drug discovery and big data Oxford UK — Genomics plc, the data science company specialising in the use of human genetic information to improve drug development, today announced that it has successfully completed a second close of its […]

Fluidic Analytics Ltd has raised $31 million to continue developing its transformational products for characterising proteins and their behaviour. The proceeds of the financing will be used to continue the commercial roll-out of the company’s lab-tools pipeline and to develop further high-value clinical applications of its technology. Proteins and their behaviour are crucial to understanding […]

Tokyo, Japan – Quantum Biosystems Inc. today announced that it has closed a Series C financing round of JPY 1 Billion ($8.9 Million), through the sale of preferred stock to SBI Investment Co., Ltd., a Japanese venture capital company. Details of the financing were not disclosed. Quantum Biosystems is developing a novel, single molecule sequencing […]

Cambridge, UK – Fluidic Analytics Ltd has raised $31 million to continue developing its transformational products for characterising proteins and their behaviour. The proceeds of the financing will be used to continue the commercial roll-out of the company’s lab-tools pipeline and to develop further high-value clinical applications of its technology. Proteins and their behaviour are crucial […]

The Government of Canada awards $1M in funding to this Québec City business Québec City, Quebec – Canada Economic Development for Quebec Regions (CED) SiliCycle is a leader in the development, manufacturing and commercialization of innovative silica-based products. The company wants to diversify its markets through the development and commercialization of products resulting from the […]

New grants support FDA’s GDUFA priorities of expanding bioequivalence methods for topical dermatological products and improving PBPK models of drug absorption via complex delivery routes  PRINCETON, NJ – Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced that it has been awarded two new dermal virtual bioequivalence grants […]

SAN FRANCISCO–Trace Genomics®, a San Francisco Bay area startup developing revolutionary, AI-enabled diagnostic tools for farmers to increase yields and reduce costs, has closed a $13 million Series A round. Trace Genomics has launched the first scalable soil microbiome test to enable the early prediction of soil diseases, soil health and crop quality. Every tablespoon […]

SAN FRANCISCO–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it has priced its initial public offering of 5,000,000 shares of its common stock at a price to the public of $14.00 per share, before underwriting discounts and commissions. All of the shares of common stock are […]

We’re excited to make two major announcements today. We have closed a $110M Series C investmentround led by Founders Fund and we have added Dr. Matthew Porteus, a pioneer in cell therapies, to our advisory board. Since the start of our journey at Synthego, we’ve been committed to making state-of-the-art genome engineering tools accessible to researchers […]